440 filings
Page 12 of 22
CT ORDER
xs6hl u5lp
19 Dec 17
Confidential treatment order
12:00am
CT ORDER
n7pb5334q7obgqdu6
19 Dec 17
Confidential treatment order
12:00am
8-K
31tup 026zsc
4 Dec 17
Regulation FD Disclosure
12:00am
CT ORDER
fbcm cdwrymgkug
30 Nov 17
Confidential treatment order
12:00am
8-K
mi8e6iido25xjjnqtsh1
12 Oct 17
AcelRx Pharmaceuticals Receives Complete Response Letter from the FDA for DSUVIA™ NDA
12:00am
8-K
wn5fqf1u2
23 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
ry71v2sp0q6a2pu
1 Aug 17
AcelRx Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
28xn5c7
19 Jul 17
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
12:00am
8-K
7dijkk
20 Jun 17
Entry into a Material Definitive Agreement
12:00am
424B5
msfrpazieoncqxkc
15 Jun 17
Prospectus supplement for primary offering
12:00am
EFFECT
3j0zyohrog
14 Jun 17
Notice of effectiveness
12:00am
CORRESP
w1f8gfx bjzx
13 Jun 17
Correspondence with SEC
12:00am
UPLOAD
zuide
12 Jun 17
Letter from SEC
12:00am
8-K
qc6f2p1sgd6dc84 m0y
7 Jun 17
Regulation FD Disclosure
12:00am
8-K
qizot32s0mh9cm
5 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
gr8ywf0tmo uvge8oa
10 May 17
Tim Morris; AcelRx Pharmaceuticals, Inc.; CFO and Head of Business Development
12:00am